Faliure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: Potential for rescue?

被引：0
作者：
Sobolewski, A. [1 ]
Rudarakanchana, N. [1 ]
Jeffery, T. K. [1 ]
Trembath, R. C. [1 ]
Morrell, N. W. [1 ]
机构：
[1] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England
来源：
THORAX | 2006年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：II11 / II11
页数：1
相关论文
共 50 条
  • [41] Heterozygous Null Bone Morphogenetic Protein Receptor Type 2 Mutations Promote SRC Kinase-dependent Caveolar Trafficking Defects and Endothelial Dysfunction in Pulmonary Arterial Hypertension
    Prewitt, Allison R.
    Ghose, Sampa
    Frump, Andrea L.
    Datta, Arumima
    Austin, Eric D.
    Kenworthy, Anne K.
    de Caestecker, Mark P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (02) : 960 - 971
  • [42] Characteristics of Pulmonary Arterial Hypertension in Affected Carriers of a Mutation Located in the Cytoplasmic Tail of Bone Morphogenetic Protein Receptor Type 2
    Girerd, Barbara
    Coulet, Florence
    Jais, Xavier
    Eyries, Melanie
    Van Der Bruggen, Cathelijne
    De Man, Frances
    Houweling, Arjan
    Dorfmueller, Peter
    Savale, Laurent
    Sitbon, Olivier
    Vonk-Noordegraaf, Anton
    Soubrier, Florent
    Simonneau, Gerald
    Humbert, Marc
    Montani, David
    CHEST, 2015, 147 (05) : 1385 - 1394
  • [43] Expression of mutant bone morphogenetic protein receptor II worsens pulmonary hypertension secondary to pulmonary fibrosis
    Bryant, Andrew J.
    Robinson, Linda J.
    Moore, Christy S.
    Blackwell, Thomas R.
    Gladson, Santhi
    Penner, Niki L.
    Burman, Ankita
    McClellan, Lucas J.
    Polosukhin, Vasiliy V.
    Tanjore, Harikrishna
    McConaha, Melinda E.
    Gleaves, Linda A.
    Talati, Megha A.
    Hemnes, Anna R.
    Fessel, Joshua P.
    Lawson, William E.
    Blackwell, Timothy S.
    West, James D.
    PULMONARY CIRCULATION, 2015, 5 (04) : 681 - 690
  • [44] The effect of estrogen on bone morphogenetic protein receptor signal pathway in pulmonary arterial endothelial cells
    Ichimori, H.
    Kogaki, S.
    Ishida, H.
    Narita, J.
    Uchikawa, T.
    Maekawa, S.
    Matsumoto, S.
    Okada, Y.
    Ozono, K.
    EUROPEAN HEART JOURNAL, 2009, 30 : 85 - 85
  • [45] Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension
    Maruyama, Hidekazu
    Dewachter, Celine
    Belhaj, Asmae
    Rondelet, Benoit
    Sakai, Satoshi
    Rernmelink, Myriam
    Vachiery, Jean-Luc
    Naeije, Robert
    Dewachter, Laurence
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (03) : 468 - 478
  • [46] Bone morphogenetic protein 9, and its genetic variants contribute to susceptibility of idiopathic pulmonary arterial hypertension
    Guo, Kefang
    Xu, Liying
    Jin, Lin
    Wang, Huilin
    Ren, Yun
    Hu, Yan
    Yu, Ying
    Cang, Jing
    AGING-US, 2020, 12 (03): : 2123 - 2131
  • [47] Sequencing of mutations in the serine/threonine kinase domain of the bone morphogenetic protein receptor type 2 gene causing pulmonary arterial hypertension
    Mutlu, Zeynep
    Kayikcioglu, Meral
    Nalbantgil, Sanem
    Vuran, Ozcan
    Kemal, Hatice
    Mogulkoc, Nesrin
    Erturk, Biray
    Onay, Huseyin
    Eroglu, Zuhal
    Kultursay, Hakan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (07) : 491 - 496
  • [48] The sonic hedgehog signaling inhibitor cyclopamine improves pulmonary arterial hypertension via regulating the bone morphogenetic protein receptor 2 pathway
    Jin, Youpeng
    Mao, Fei
    Wang, Xuehui
    Zhang, Jie
    Gao, Yanting
    Fan, Youfei
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [49] Bone Morphogenetic Protein Receptor 2 Expression Is Reduced in Blood Across Pulmonary Arterial Hypertension Subtypes but Does Not Reflect Disease Severity
    Sweatt, A.
    Wells, R. E.
    Purington, N.
    Hedlin, H.
    Sudheendra, D.
    Hsi, A.
    Zamanian, R. T.
    Spiekerkoetter, E. F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [50] Prevalence of bone morphogenetic protein receptor type II and activin receptor-like kinase-1 gene mutation in pulmonary arterial hypertension
    Nakanishi, N
    Kyotani, S
    Oya, H
    Nitoube, J
    Morisaki, H
    Morisaki, T
    CIRCULATION, 2004, 110 (17) : 719 - 719
12345